(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 112.08%123.56M | ---- | -196.13%-1.02B | ---- | 31.61%1.06B | ---- | -64.23%808.41M | ---- | -34.74%2.26B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -3.09%-184.39M | ---- | 28.20%-178.86M | ---- | -11.81%-249.12M | ---- | -0.48%-222.8M | ---- | -17.31%-221.74M | ---- |
Attributable subsidiary (profit) loss | -72.87%175.98M | ---- | 200.64%648.65M | ---- | 9,867.04%215.75M | ---- | -115.62%-2.21M | ---- | 2.17%14.14M | ---- |
Impairment and provisions: | 23.20%676.7M | --0 | 1,717.46%549.26M | --0 | -110.80%-33.96M | --0 | 280.48%314.43M | --0 | 59.54%82.64M | --0 |
-Impairmen of inventory (reversal) | -8.61%503.03M | ---- | 1,256.36%550.4M | ---- | -115.87%-47.6M | ---- | 246.81%299.89M | ---- | 90.95%86.47M | ---- |
-Other impairments and provisions | 15,266.90%173.66M | ---- | -108.39%-1.15M | ---- | -6.15%13.64M | ---- | 479.28%14.53M | ---- | -158.83%-3.83M | ---- |
Revaluation surplus: | -96.68%2.28M | --0 | -55.16%68.81M | --0 | 203.38%153.47M | --0 | 148.80%50.59M | --0 | 25.46%-103.66M | --0 |
-Fair value of investment properties (increase) | -96.68%2.28M | ---- | -55.16%68.81M | ---- | 203.38%153.47M | ---- | 148.80%50.59M | ---- | 25.78%-103.66M | ---- |
Asset sale loss (gain): | --0 | --0 | --0 | --0 | --0 | --0 | ---955K | --0 | --0 | --0 |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---955K | ---- | ---- | ---- |
Depreciation and amortization: | -33.98%30.37M | --0 | -16.76%46M | --0 | 41.31%55.26M | --0 | 57.91%39.11M | --0 | 199.52%24.76M | --0 |
-Depreciation | -33.98%30.37M | ---- | -16.76%46M | ---- | 41.31%55.26M | ---- | 57.91%39.11M | ---- | 199.52%24.76M | ---- |
Financial expense | 245.59%477.42M | ---- | -15.29%138.14M | ---- | 134.74%163.08M | ---- | 159.81%69.47M | ---- | --26.74M | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---271.62M | ---- | ---- | ---- |
Operating profit before the change of operating capital | 422.35%1.3B | --0 | -81.79%249.25M | --0 | 74.45%1.37B | --0 | -62.34%784.42M | --0 | -37.76%2.08B | --0 |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 110.83%6.46B | ---- | 6,691.26%3.07B | ---- | 108.48%45.15M | ---- | 24.30%-532.59M | ---- | 49.54%-703.55M | ---- |
Accounts payable increase (decrease) | 63.68%-644.81M | ---- | -148.84%-1.78B | ---- | 194.19%3.63B | ---- | -582.24%-3.86B | ---- | -71.47%800.25M | ---- |
prepayments (increase)decrease | 148.67%37.89M | ---- | 96.02%-77.85M | ---- | 49.16%-1.96B | ---- | -600.12%-3.85B | ---- | -58.02%-549.36M | ---- |
Cash from business operations | 247.16%2.15B | 192.02%1.21B | -129.66%-1.46B | -122.40%-1.31B | 498.20%4.92B | 441.39%5.86B | -817.30%-1.24B | ---1.72B | -70.45%172.18M | --0 |
Other taxs | 36.84%-409.32M | 55.39%-116.91M | 51.18%-648.12M | 82.54%-262.08M | -292.33%-1.33B | -2,602.18%-1.5B | 70.21%-338.35M | ---55.56M | 26.65%-1.14B | ---- |
Interest paid - operating | -37.28%-1.32B | -56.94%-632.73M | -16.52%-958.52M | -3.79%-403.16M | -11.33%-822.61M | 10.84%-388.44M | 7.22%-738.91M | ---435.65M | -15.19%-796.41M | ---- |
Special items of business | -71.59%-5.01B | ---- | -260.06%-2.92B | ---- | -70.65%1.82B | ---- | 526.47%6.22B | ---- | 61.90%-1.46B | ---- |
Net cash from operations | 113.75%421.5M | 123.20%459.15M | -210.75%-3.07B | -149.78%-1.98B | 219.70%2.77B | 279.94%3.98B | -31.37%-2.31B | -488.17%-2.21B | -6.20%-1.76B | 134.65%569.14M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 3.09%184.39M | 9.24%95.07M | -28.20%178.86M | 112.01%87.03M | 40.31%249.12M | -42.37%41.05M | -19.93%177.55M | -2.80%71.22M | 17.31%221.74M | -25.74%73.28M |
Loan receivable (increase) decrease | 286.99%1.22B | 50.20%-53.98M | -14.20%-652.86M | 84.65%-108.4M | -459.01%-571.66M | -329.20%-706.07M | -55.08%159.23M | 443.49%308.06M | 538.49%354.49M | 118.35%56.68M |
Sale of fixed assets | -74.03%214K | -69.13%113K | 191.17%824K | 242.06%366K | -70.18%283K | -84.36%107K | 105.41%949K | 160.08%684K | 73.68%462K | 126.72%263K |
Purchase of fixed assets | -854.36%-56.39M | -178.84%-17.95M | 21.18%-5.91M | -116.37%-6.44M | 82.90%-7.5M | 32.05%-2.98M | -226.92%-43.83M | -51.75%-4.38M | 17.32%-13.41M | 31.18%-2.89M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---487.33M | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --478.32M | ---- | ---- | ---- |
Cash on investment | -1,497.84%-45.84M | ---18.12M | 98.89%-2.87M | ---- | -375.68%-257.87M | ---96.52M | ---54.21M | ---- | ---- | ---- |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -260.59%-162.13M | ---- | ---44.96M |
Net cash from investment operations | 370.39%1.3B | 118.72%5.14M | 17.98%-481.95M | 96.41%-27.44M | -354.75%-587.64M | -458.11%-764.41M | -59.05%230.67M | 159.14%213.46M | 550.87%563.29M | 138.43%82.37M |
Net cash before financing | 148.62%1.72B | 123.14%464.29M | -262.71%-3.55B | -162.49%-2.01B | 204.73%2.18B | 260.88%3.21B | -73.92%-2.08B | -406.33%-2B | 23.81%-1.2B | 135.08%651.51M |
Cash flow from financing activities | ||||||||||
New borrowing | 137.45%7.99B | 191.41%4.16B | -19.67%3.36B | -66.52%1.43B | -63.06%4.19B | -52.58%4.27B | 228.79%11.34B | 403.69%9B | -17.77%3.45B | -33.37%1.79B |
Refund | -3,538.88%-12.59B | -569.37%-4.96B | 112.35%366.19M | 205.45%1.06B | 62.74%-2.96B | 86.02%-1B | -248.44%-7.95B | -485.48%-7.17B | 55.23%-2.28B | 64.70%-1.23B |
Dividends paid - financing | -330.80%-1.2B | ---- | 9.63%-278.3M | -95.27%-106.19M | 37.17%-307.95M | -0.21%-54.38M | -0.65%-490.1M | 83.18%-54.27M | 55.93%-486.92M | -60.76%-322.71M |
Absorb investment income | ---- | ---- | -99.83%2.02M | ---- | -45.93%1.21B | ---- | 305.82%2.24B | --328K | --551.68M | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---1.56B | ---1.56B | ---- | ---- | ---- | ---- |
Other items of the financing business | 95.28%-106.58M | 95.88%-96.6M | -7,451.06%-2.26B | -17,894.68%-2.34B | -102.24%-29.88M | -45.73%-13.02M | 541.53%1.34B | -1,113.45%-8.93M | -86.61%208.17M | -100.05%-736K |
Net cash from financing operations | -592.90%-5.91B | -2,476.01%-898.25M | 123.03%1.2B | -97.69%37.81M | -91.69%537.45M | -7.01%1.64B | 349.56%6.47B | 641.27%1.76B | 417.50%1.44B | -62.10%237.41M |
Effect of rate | 88.21%-106.83M | 50.25%-233.83M | ---906.07M | -622.12%-470.04M | ---- | 256.65%90.03M | ---- | -349.55%-57.47M | ---- | 71.42%-12.78M |
Net Cash | -78.13%-4.18B | 77.95%-433.96M | -186.42%-2.35B | -140.61%-1.97B | -38.07%2.72B | 2,154.65%4.85B | 1,710.99%4.39B | -126.54%-235.92M | 111.97%242.32M | 172.23%888.91M |
Begining period cash | -29.71%7.7B | -29.71%7.7B | 32.99%10.96B | 32.99%10.96B | 113.98%8.24B | 113.98%8.24B | 6.72%3.85B | 6.72%3.85B | -35.94%3.61B | -35.94%3.61B |
Cash at the end | -55.71%3.41B | -17.42%7.03B | -29.71%7.7B | -35.35%8.52B | 32.99%10.96B | 270.45%13.18B | 113.98%8.24B | -20.68%3.56B | 6.72%3.85B | 2.92%4.48B |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data